Anuh Pharma is currently trading at Rs. 149.00, up by 4.05 points or 2.79% from its previous closing of Rs. 144.95 on the BSE.
The scrip opened at Rs. 152.70 and has touched a high and low of Rs. 152.85 and Rs. 145.40 respectively. So far 81 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 173.00 on 14-Nov-2018 and a 52 week low of Rs. 101.25 on 02-Aug-2019.
Last one week high and low of the scrip stood at Rs. 161.40 and Rs. 143.75 respectively. The current market cap of the company is Rs. 374.46 crore.
The promoters holding in the company stood at 71.78%, while Non-Institutions held 28.22% stake in the company.
Anuh Pharma has received European Union Good Manufacturing Practices (EuGMP) Certificate from AEMPS- Spanish Health Authority for five products for the inspection held on November 26, 2018 to November 28, 2018. The products are Erythromycin, Erythromycin Ethyl Succinate, Pyrazinamide, Sulfadoxine and Pyrimethamine.
Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1529.55 |
Dr. Reddys Lab | 6315.00 |
Cipla | 1423.40 |
Zydus Lifesciences | 1021.00 |
Lupin | 1679.75 |
View more.. |